In vivo imaging of cerebral serotonin transporter and serotonin2A receptor binding in 3, 4-methylenedioxymethamphetamine (MDMA or “ecstasy”) and hallucinogen …

D Erritzoe, VG Frokjaer, KK Holst… - Archives of General …, 2011 -

Author(s): Vibe Frokjaer , Klaus Kahler Holst

Focus: MDMA


Context Both hallucinogens and 3, 4-methylenedioxymethamphetamine (MDMA or “ecstasy”) have direct agonistic effects on postsynaptic serotonin 2A receptors, the key site for hallucinogenic actions. In addition, MDMA is a potent releaser and reuptake inhibitor of …

Last updated: Jul 27, 2020